Business Context and Reporting Period
This Form 8-K was filed by Conversion Labs, Inc. (not Lifemd, Inc.) on September 30, 2020, reporting events occurring on September 29, 2020. The filing details an amendment to a material definitive consulting agreement with Blue Horizon Consulting, LLC, a firm owned by Board member Happy Walters, to assist in developing the company's telemedicine business.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The primary financial implication is the potential issuance of up to 10,000,000 shares of common stock to the consultant upon the achievement of certain revenue milestones.
Material Changes
- Compensation Structure: The company amended its original 2019 Consulting Agreement to change the compensation model retroactively to the original agreement's effective date.
- Equity Issuance: The amendment authorizes the issuance of up to 10,000,000 shares of common stock to Blue Horizon Consulting, LLC, subject to adjustment and contingent on reaching specific revenue targets.
- Related Party Transaction: The agreement involves a related party, as Happy Walters, a member of the Board of Directors, is the sole owner of the consulting firm. The amendment was approved by disinterested directors.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure of the related-party transaction. The primary contingency is the achievement of revenue milestones required to trigger the issuance of the 10,000,000 shares.
Investor Verification Checklist
- Verify the specific revenue milestones required to trigger the issuance of the 10,000,000 shares by reviewing Exhibit 10.1 (Amended Consulting Agreement).
- Confirm the current share count and the potential dilution impact of issuing 10,000,000 additional shares.
- Review the company's recent financial statements to assess current revenue levels relative to the new milestones.
- Check for any subsequent filings regarding the status of the telemedicine business development.